Mol Genet Genomics. 2024 Oct 26. 299(1): 102
Zhimei Liu,
Yaojun Xie,
Xiaoting Lou,
Xiaofei Zeng,
Luyi Zhang,
Meng Yu,
Junling Wang,
Jiuwei Li,
Danmin Shen,
Hua Li,
Suzhou Zhao,
Yuwei Zhou,
Hezhi Fang,
Jianxin Lyu,
Yun Yuan,
Zhaoxia Wang,
Liqin Jin,
Fang Fang.
The MELAS/Leigh overlap syndrome manifests with a blend of clinical and radiographic traits from both MELAS and LS. However, the association of MELAS/Leigh overlap syndrome with MT-CO1 gene variants has not been previously reported. In this study, we report a patient diagnosed with MELAS/Leigh overlap syndrome harboring the m.5906G > A variant in MT-CO1, with biochemical evidence supporting the pathogenicity of the variant. The variant m.5906G > A that led to a synonymous variant in the start codon of MT-CO1 was filtered as the candidate disease-causing variant of the patient. Patient-derived fibroblasts were used to generate a series of monoclonal cells carrying different m.5906G > A variant loads for further functional assays. The oxygen consumption rate, ATP production, mitochondrial membrane potential and lactate assay indicated an impairment of cellular bioenergetics due to the m.5906G > A variant. Blue native PAGE analysis revealed that the m.5906G > A variant caused a deficiency in the content of mitochondrial oxidative phosphorylation complexes. Furthermore, molecular biology assays performed for the pathogenesis, mtDNA copy number, mtDNA-encoded subunits, and recovery capacity of mtDNA were all deficient due to the m.5906G > A variant, which might be caused by mtDNA replication deficiency. Overall, our findings demonstrated the pathogenicity of m.5906G > A variant and proposed a potential pathogenic mechanism, thereby expanding the genetic spectrum of MELAS/Leigh overlap syndrome.
Keywords: M.5906G > A; MT-CO1
; MELAS/Leigh overlap syndrome; MtDNA replication